Furthermore, the elevated glucose consumption (Figure 8E) and lactate production (Figure 8F) in tumours of the Exos treatment group were reversed by miR‐3126‐5p deficiency, which were restored by KLF13 knockdown. The gene discussed is KLF13; the disease is neoplasm.